A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma

Familial Cancer

Volumn 9, Issue 3, 2010, Pages 425-430

  Abbaszadeh, Fatemeh ^a   Barker, Karen T ^a   McConville, Carmel ^b   Scott, Richard H ^a   Rahman, Nazneen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Embryonal tumors; Familial cancer syndrome; Familial neuroblastoma; Familial Wilms tumor; Neuroblastoma; Wilms tumor

Indexed keywords

WT1 PROTEIN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COPY NUMBER VARIATION; DNA SEQUENCE; EPIGENETICS; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; INFANT; MALE; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADULT; CHILD, PRESCHOOL; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; GENES, WILMS TUMOR; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEUROBLASTOMA; PEDIGREE; PROTEIN-TYROSINE KINASES; SYNDROME; TRANSCRIPTION FACTORS; WILMS TUMOR;

EID: 78650206380     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9319-8     Document Type: Article

References (25)

1. Maris JM, Denny CT (2002) Focus on embryonal malignancies. Cancer Cell 2:447-450
2. Stiller CA, Parkin DM (1990) International variations in the incidence of childhood renal tumors. Br J Cancer 62:1026-1030
3. Bolande RP (1977) Childhood tumors and their relationships to birth defects. In: Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds) Genetics of human cancer. Raven, New York, pp 43-75
4. Breslow N, Beckwith JB, Ciol M et al (1988) Age distribution of Wilms' tumor: report from the national Wilms' tumor study. Cancer Res 48:1653-1657
5. Scott RH, Stiller CA, Walker L et al (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumor. J Med Genet 43:705-715
6. Little SE, Hanks SP, King-Underwood L et al (2004) Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK children's cancer study group study. J Clin Oncol 22:4140-4146
7. Scott RH, Douglas J, Baskcomb L et al (2008) Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause non-syndromic Wilms tumor. Nat Genet 40:1329-1334
8. Rahman N, Arbour L, Tonin P et al (1996) Evidence for a familial Wilms' tumor gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461-643
9. McDonald JM, Douglass EC, Fisher R et al (1998) Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58:1387-1390
10. Shimada H, Ambros IM, Dehner LP et al (1999) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364-372
11. Castleberry RP (1997) Neuroblastoma. Eur J Cancer 33:1430-1437
12. Amiel J, Laudier B, Attié-Bitach T et al (2003) Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459-461
13. Tatton-Brown K, Douglas J, Coleman K et al (2005) Genotypephenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77:193-204
14. Cohen MM Jr (2005) Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 8:287-304
15. McConville C, Reid S, Baskcomb L et al (2006) PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. Am J Med Genet A 140:1297-1301
16. Mossé YP, Laudenslager M, Longo L et al (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935
17. DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann syndrome registry. J Pediatr 132:398-400
18. Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274-278
19. Rahman N (2005) Mechanisms predisposing to childhood overgrowth and cancer. Curr Opin Genet Dev 15:227-233
20. Reid S, Renwick A, Seal S et al (2005) Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumor. J Med Genet 42:147-151
21. Faivre L, Portnöi MF, Pals G et al (2005) Should chromosome breakage studies be performed in patients with VACTERL association? Am J Med Genet A 137:55-58
22. Reid S, Schindler D, Hanenberg H et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162-164
23. Scott RH, Douglas J, Baskcomb L (2008) Methylation-specific MLPA (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J Med Genet 45:106-113
24. London WB, Castleberry RP, Matthay KK et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children's oncology group. J Clin Oncol 23:6459-6465
25. Cohn SL, Pearson AD, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289-297